Remus Pharmaceuticals Limited

Company Profile
Company Name Remus Pharmaceuticals Limited
Open Date 17-05-2023
Close Date 19-05-2023
Exchange NSE SME
Lot Size 100 shares
Issue Price ₹ 1229 per share
Issue Size 3,88,000 Equity Shares
Application Amount ₹ 1,22,900
Recommendation Avoid
Remus Pharmaceuticals Limited was originally incorporated as ‘Remus Pharmaceuticals Private Limited’ in September 21, 2015. Headquartered in Ahmedabad, Gujarat. Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. Company also deals in API (Active Pharmaceutical Ingredient). They also provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. Company is majorly engrossed in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical finished formulations and products. Depending upon business requirements, they get finished pharmaceutical formulations manufactured on loan license or contract manufacturing. Such manufacturing is on principle-to-principle basis.
(Read more on the review)

Summary of Financials (All financials in Lakh)

For the Period Ended Mar-21 Mar-22 Mar-23
Total Assets 1,104.96 1,590.93 3,352.96
Net Assets 304.61 643.18 1,712.07
Total Borrowings 27.89 19.17 947.45
Total Revenue 1,922.45 2,543.71 3,361.19
Profit After Tax 102.58 338.57 643.89

Tentative Timeline

Opening Date 17-05-2023
Closing Date 19-05-2023
Basis of Allotment 24-05-2023
Initiation of Refunds 25-05-2023
Credit of Shares to Demat 26-05-2023
Listing Date 29-05-2023

Objects of the Issue

To Meet Working Capital Requirements.
Funding investments for acquisitions and general corporate purposes.
To meet Public Issue Expenses.

Contact Information

Registered Office Remus Pharmaceuticals Limited 1101 to 1103, South Tower, One 42, B/H Ashok Vatika, Nr. Jayantilal Park BRTS, Ambli bopal Road, Ahmedabad - 380054
Phone 079- 2999 9857

Registrar Details

Name Link Intime India Private Ltd
Phone 91-22-4918 6270

IPO Reservation

Anchor Investor Shares Offered 1,10,500 (27.12%)
Market Maker Shares Offered 19,500 (4.79%)
QIB Shares Offered 1,38,750 (34.05%)
NII (HNI) Shares Offered 41,625 (10.21%)
Retail Shares Offered 97,125 (23.83%)
Total Shares Offered 4,07,500 (100%)

Shareholding Pattern

Share Holding Pre Issue (Promoters) 92.82%
Share Holding Post Issue (Promoters) 68.37%

Contact Us to Enable Your Success!